An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 2, 1996, Pages 128-133

  Krieg, Arthur M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030205135     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90004-9     Document Type: Conference Paper

References (37)

1. Tokunaga T, Yamamoto H, Shimada S, et al. Antitumor activity of deoxyribonucleic acid fraction from mycobacterium bovis GCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984;72:955-62.
2. Yamamoto S, Kuramoto E, Shimada S, Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from mycobacterium bovis BCG. Jpn J Cancer Res 1988;79: 866-73.
3. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J Immunol 1992;148: 4072-6.
4. Kuramoto E, Yano O, Kimura, et al. Oligonucleotide sequences required for natural killer cell activation. Jpn J Cancer Res 1992;83:1128-31.
5. Messina JP, Gilkeson GS, Pisetsky DS. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 1991;147:1759-64.
6. Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, et al. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 1992;36:983-97.
7. Krieg AK, Yi A-K, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-9.
8. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986;321:209-13.
9. Klinman D, Yi A-K, Beaucage SL, Conover J, Krieg AM. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN. Proc Natl Acad Sci USA 1996;93:2879-83.
10. Halpern MD, Kurlander RJ, Pisetsky DS. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell Immunol 1996;167:72-8.
11. Bennett RM, Gabor GT, Merritt MM. DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. J Clin Invest 1985;76:2182-90.
12. Zhao Q, Waldschmidt T, Fisher E, Herrera CJ, Krieg AM. Stage specific oligonucleotide uptake in murine bone marrow B cell precursors. Blood 1994;84:3660-6.
13. Krieg AM, Steinberg AD. Potential of antisense technology in the treatment of immunological disorders. Clin Immunother 1995;4:169-79.
14. Akhtar S, Shoji Y, Juliano RL. Pharmaceutical aspects of the biological stability and membrane transport characteristics of antisense oligonucleotides. In: Erickson RP, Izant JG, editors. Gene regulation: biology of antisense RNA and DNA. New York: Raven Press Ltd., 1992;133-45.
15. Chused TM, Steinberg AD, Talal N. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol 1972;12:465-76.
16. Emlen W, Mannik M. Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol 1984;56:185-92.
17. Agrawal S, Tensamani J, Galbraith W, Tang J. Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 1995;28:7-16.
18. Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR. Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol 1992;90:56-62.
19. 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol 1994;45:932-43.
20. Iguchi-Ariga SMM, Schaffner W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 1989;3:612-9.
21. Xie H, Chiles TC, Rothstein TL. Induction of CREB activity via the surface Ig receptor of B cells. J Immunol 1993;151:880-9.
22. Xie H, Rothstein TL. Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in B lymphocytes stimulated through surface Ig. J Immunol 1995;154:1717-23.
23. Lemaigre FP, Ace CI, Green MR. The cAMP response element binding protein, CREB, is a potent inhibitor of diverse transcriptional activators. Nucleic Acids Res 1993;21: 2907-11.
24. Branda RF, Moore AL, Hong R, McCormack JJ, Zon G, Cunningham-Rundles C. B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1. Clin Immunol Immunopathol (in press).
25. Kataoka T, Yamamoto S, Yamamoto T, Kuramoto E, Kimura Y, Yano O, et al. Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG. Jpn J Cancer Res 1992; 83:244-7.
26. Azad RF, Driver VB, Tanaka K, Crooke RM, Anderson KP. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob Agents Chemother 1993;37:1945-54.
27. Karlin S, Doerfler W, Cardon LR. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 1994;68:2889-97.
28. Branda RF, Moore AL, Mathews L, McCormack JJ, Zon G. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. Biochem Pharmacol 1993;45: 2037-43.
29. Krieg AM. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J Clin Immunol 1995;15:284-92.
30. Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 1989;142:1482-6.
31. Gilkeson GS, Pippen AMM, Pisetsky DS. Induction of crossreactive anti-dsDNA antibodies in preautoimmune NZB/ NZW mice by immunization with bacterial DNA. J Clin Invest 1995;95:1398-402.
32. Sano H, Morimoto C. DNA isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J Immunol 1982;128:1341-5.
33. Van Helden PD. Potential Z-DNA-forming elements in serum DNA from human systemic lupus erythematosus. J Immunol 1985;134:177-9.
34. Sano H, Takai O, Harata N, Yoshinaga K, Kodama-Kamada I, Sasaki T. Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand J Immunol 1989;30:51-63.
35. Krapf F, Herrmann M, Leitmann W, Kalden JR. Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients. Clin Exp Immunol 1989;75:336-42.
36. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990;33:1665-73.
37. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanisms of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995;154:3025-35.